Brief: Melodiol Global Health Says Q2 2024 Unaudited Revenues Total A$4.8M
July 3 (Reuters) - Melodiol Global Health Ltd ME1.AX :
* Q2 2024 UNAUDITED REVENUES TOTAL A$4.8M
* DURING Q2 OF 2024, MERNOVA HAD CONFIRMED UNAUDITED
PURCHASE
ORDERS OF A$2.0M
Further company coverage: ME1.AX
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale